TheralinkTheralink

  • Theralink
    • The Theralink platform
    • The Theralink Assay
    • Request RPPA Analyte List
    • RPPA Clinical Publications
    • RPPA Research Publications
    • RPPA Technical Publications
  • About
    • Overview
    • Oncologists
    • Mission Statement
    • Management Team
    • Medical Advisory Board
    • Scientific Advisory Board
    • Board of Directors
    • Career
  • News & Media
    • Press Releases
    • Media Coverage
  • Biopharmas
    • Overview
    • Explore Technology
    • Explore Targets
    • Explore Pathways
    • Build-a-Pathway
    • FAQ
  • INVESTOR RELATIONS
    • Overview
    • Press Releases
    • Events & Presentations
    • Financial Information
    • Stock Information
    • Investor Resources
      • FAQ
      • Contact Us
    • Corporate Governance
      • Management Team
      • Medical Advisory Board
      • Scientific Advisory Board
      • Board of Directors
  • Contact

News and Media

Theralink   →  Media Room
Posted on July 8, 2020

Theralink® Technologies Announces Strategic Agreement with VieCure to Improve Outcomes for Breast Cancer Patients Being Treated in Community Oncology Settings

  Theralink® Technologies Announces Strategic Agreement with VieCure to Improve Outcomes for Breast Cancer Patients Being...
Read More
Posted on June 17, 2020June 17, 2020

OncBioMune d/b/a Theralink® Technologies Launches New Corporate Website

  Golden, Colorado – June 17, 2020 – OncBioMune (OTC: OBMP) d/b/a Theralink Technologies, a molecular profiling compan...
Read More
Posted on June 10, 2020June 11, 2020

OncBioMune Appoints Dr. Mick Ruxin as President & CEO and Jeffrey Busch as Chairman of the Board

  Golden, Colorado - June 10, 2020 - OncBioMune Pharmaceuticals, Inc. (OTC: OBMP) (“OncBioMune”) today announced the a...
Read More
Posted on June 8, 2020June 11, 2020

OncBioMune Announces Closing of Asset Purchase Agreement with Avant Diagnostics

  Avant Diagnostics provides personalized medicine data for physicians and measures the activation state of key drug targets...
Read More
Posted on March 24, 2020April 15, 2020

American Association for Cancer Research/AACR

Annual Conference 2020 San Diego CA Convention Center Dates April 24, 2020 thru April 29, 2020 Cancelled  ...
Read More
Posted on March 23, 2020April 15, 2020

American Society of Clinical Oncology/ASCO

Annual Conference 2020 McCormick Place Chicago IL Dates May 29, 2020 thru June 02, 2020 Cancelled...
Read More
Posted on March 22, 2020April 15, 2020

San Antonio Breast Cancer Symposium/SABCS

Annual Conference 2020 Henry B. Gonzalez Convention Center Dates December 08, 2020 thru December 12, 2020...
Read More
Previous page 1 2

Categories

  • Events
  • Investor Presentation
Theralink Technologies intends to be a market leader in precision medicine for more effective cancer treatments

Menu

  • About
  • Investors
  • Contact
  • Privacy Policy

OUR SERVICES

  • Biopharmas
  • Oncologists
  • Media Room

Press Releases

  • Theralink® Technologies Issues Letter to Shareholders
  • Theralink® Technologies Announces Partnership with Perthera to Facilitate and Accelerate Access to its Unique Phosphoprotein and Drug Target Activation Testing in the U.S.
  • Theralink® Technologies Appoints Thomas Chilcott as Chief Financial Officer
Copyright © 2020 Theralink. All rights reserved.
We use cookies to improve your experience on our site. If you continue the use of this site then you accept our terms of use and privacy policy.Terms & Privacy